Share Price and Basic Stock Data
Last Updated: October 9, 2025, 12:40 am
| PEG Ratio | -5.22 |
|---|
Analyst Insight & Comprehensive Analysis
Diamines & Chemicals Ltd, currently priced at ₹298 with a market capitalization of ₹294 Cr, presents a unique financial profile in the chemicals sector. With a high P/E ratio of 177 and a ROE of 1.78%, the company’s profitability metrics are notably below industry averages. Its negative operating profit margin of -32.24% raises concerns about operational efficiency, further highlighted by a ROCE of 3.33%, indicating suboptimal capital utilization. However, the company’s low debt level, with borrowings at just ₹0.03 Cr, and a healthy interest coverage ratio of 25.34x, signal a strong balance sheet position compared to peers in the sector.
One of Diamines & Chemicals Ltd’s key strengths lies in its significant promoter holding of 55.21%, indicating a strong alignment of interests with shareholders. Additionally, the company’s moderate price-to-book value of 1.90x suggests a relatively attractive valuation compared to industry peers. However, risks include the low institutional ownership by FIIs and DIIs, potentially impacting liquidity and market interest. Moving forward, improving operational efficiency, enhancing ROE and ROCE figures, and increasing institutional investor participation could bolster the company’s growth prospects and stock performance.
In conclusion, while Diamines & Chemicals Ltd shows resilience in its financial structure and ownership pattern, addressing operational inefficiencies and attracting institutional investors could be pivotal in driving sustainable value creation for shareholders in the future. Stay vigilant about the company’s strategic initiatives to navigate potential risks and capitalize on growth opportunities in the dynamic chemicals industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Diamines & Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Diamines & Chemicals Ltd | 291 Cr. | 296 | 577/289 | 175 | 165 | 0.34 % | 3.33 % | 1.78 % | 10.0 |
| Deco-Mica Ltd | 31.5 Cr. | 75.0 | 97.0/56.0 | 13.8 | 64.1 | 0.00 % | 11.8 % | 7.51 % | 10.0 |
| Andhra Sugars Ltd | 1,090 Cr. | 80.3 | 110/64.9 | 20.2 | 117 | 1.00 % | 3.54 % | 2.51 % | 2.00 |
| Tamil Nadu Petro Products Ltd | 1,017 Cr. | 113 | 119/63.6 | 14.2 | 101 | 1.06 % | 6.97 % | 5.10 % | 10.0 |
| SRF Ltd | 88,025 Cr. | 2,973 | 3,325/2,127 | 61.5 | 426 | 0.24 % | 12.3 % | 10.4 % | 10.0 |
| Industry Average | 13,679.33 Cr | 1,050.46 | 49.74 | 182.76 | 0.38% | 10.57% | 8.89% | 7.60 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23.02 | 26.98 | 24.87 | 35.69 | 31.70 | 19.92 | 23.03 | 29.38 | 16.84 | 19.19 | 17.51 | 17.93 | 12.25 |
| Expenses | 8.33 | 10.61 | 12.75 | 23.32 | 22.11 | 14.93 | 18.31 | 26.00 | 18.20 | 15.58 | 15.99 | 16.24 | 16.20 |
| Operating Profit | 14.69 | 16.37 | 12.12 | 12.37 | 9.59 | 4.99 | 4.72 | 3.38 | -1.36 | 3.61 | 1.52 | 1.69 | -3.95 |
| OPM % | 63.81% | 60.67% | 48.73% | 34.66% | 30.25% | 25.05% | 20.50% | 11.50% | -8.08% | 18.81% | 8.68% | 9.43% | -32.24% |
| Other Income | 0.56 | 0.66 | 0.54 | 0.98 | 0.70 | 0.61 | 0.58 | 0.66 | 0.66 | 0.81 | 0.77 | 0.93 | 1.89 |
| Interest | 0.04 | 0.02 | 0.04 | 0.05 | 0.04 | 0.04 | 0.13 | -0.01 | 0.03 | 0.06 | 0.17 | 0.09 | 0.01 |
| Depreciation | 0.42 | 0.44 | 0.45 | 0.47 | 0.50 | 0.69 | 0.94 | 0.73 | 0.86 | 0.88 | 0.88 | 0.87 | 0.89 |
| Profit before tax | 14.79 | 16.57 | 12.17 | 12.83 | 9.75 | 4.87 | 4.23 | 3.32 | -1.59 | 3.48 | 1.24 | 1.66 | -2.96 |
| Tax % | 25.49% | 25.29% | 26.54% | 25.33% | 28.21% | 23.61% | 30.50% | 33.43% | 6.92% | 27.30% | 34.68% | 20.48% | -7.43% |
| Net Profit | 11.02 | 12.37 | 8.93 | 9.57 | 7.01 | 3.41 | 2.80 | 2.25 | -1.75 | 2.46 | 0.75 | 1.26 | -2.81 |
| EPS in Rs | 11.26 | 12.64 | 9.13 | 9.78 | 7.17 | 3.49 | 2.86 | 2.30 | -1.79 | 2.51 | 0.77 | 1.29 | -2.87 |
Last Updated: August 19, 2025, 8:00 pm
Below is a detailed analysis of the quarterly data for Diamines & Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 12.25 Cr.. The value appears to be declining and may need further review. It has decreased from 17.93 Cr. (Mar 2025) to 12.25 Cr., marking a decrease of 5.68 Cr..
- For Expenses, as of Jun 2025, the value is 16.20 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.24 Cr. (Mar 2025) to 16.20 Cr., marking a decrease of 0.04 Cr..
- For Operating Profit, as of Jun 2025, the value is -3.95 Cr.. The value appears to be declining and may need further review. It has decreased from 1.69 Cr. (Mar 2025) to -3.95 Cr., marking a decrease of 5.64 Cr..
- For OPM %, as of Jun 2025, the value is -32.24%. The value appears to be declining and may need further review. It has decreased from 9.43% (Mar 2025) to -32.24%, marking a decrease of 41.67%.
- For Other Income, as of Jun 2025, the value is 1.89 Cr.. The value appears strong and on an upward trend. It has increased from 0.93 Cr. (Mar 2025) to 1.89 Cr., marking an increase of 0.96 Cr..
- For Interest, as of Jun 2025, the value is 0.01 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.09 Cr. (Mar 2025) to 0.01 Cr., marking a decrease of 0.08 Cr..
- For Depreciation, as of Jun 2025, the value is 0.89 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.87 Cr. (Mar 2025) to 0.89 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is -2.96 Cr.. The value appears to be declining and may need further review. It has decreased from 1.66 Cr. (Mar 2025) to -2.96 Cr., marking a decrease of 4.62 Cr..
- For Tax %, as of Jun 2025, the value is -7.43%. The value appears to be improving (decreasing) as expected. It has decreased from 20.48% (Mar 2025) to -7.43%, marking a decrease of 27.91%.
- For Net Profit, as of Jun 2025, the value is -2.81 Cr.. The value appears to be declining and may need further review. It has decreased from 1.26 Cr. (Mar 2025) to -2.81 Cr., marking a decrease of 4.07 Cr..
- For EPS in Rs, as of Jun 2025, the value is -2.87. The value appears to be declining and may need further review. It has decreased from 1.29 (Mar 2025) to -2.87, marking a decrease of 4.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 2:09 pm
| Metric | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 66.86 | 57.40 | 43.94 | 39.09 | 35.58 | 62.82 | 65.97 | 110.34 | 103.97 | 71.47 |
| Expenses | 56.54 | 49.64 | 38.12 | 34.16 | 31.12 | 37.20 | 43.90 | 54.72 | 81.29 | 66.04 |
| Operating Profit | 10.32 | 7.76 | 5.82 | 4.93 | 4.46 | 25.62 | 22.07 | 55.62 | 22.68 | 5.43 |
| OPM % | 15.44% | 13.52% | 13.25% | 12.61% | 12.54% | 40.78% | 33.45% | 50.41% | 21.81% | 7.60% |
| Other Income | 0.38 | 0.23 | 0.30 | 0.18 | 0.36 | 2.05 | 1.79 | 2.65 | 2.56 | 3.18 |
| Interest | 3.59 | 3.81 | 3.26 | 3.41 | 2.75 | 0.08 | 0.09 | 0.14 | 0.20 | 0.34 |
| Depreciation | 2.16 | 2.39 | 2.43 | 2.03 | 1.99 | 1.79 | 1.67 | 1.78 | 2.85 | 3.49 |
| Profit before tax | 4.95 | 1.79 | 0.43 | -0.33 | 0.08 | 25.80 | 22.10 | 56.35 | 22.19 | 4.78 |
| Tax % | 28.89% | 25.14% | 9.30% | 378.79% | -212.50% | 18.64% | 24.34% | 25.64% | 28.39% | 38.08% |
| Net Profit | 3.52 | 1.35 | 0.39 | -1.59 | 0.25 | 20.99 | 16.71 | 41.90 | 15.47 | 2.73 |
| EPS in Rs | 3.60 | 1.38 | 0.40 | -1.63 | 0.26 | 21.46 | 17.08 | 42.83 | 15.81 | 2.79 |
| Dividend Payout % | 27.78% | 3.62% | 0.00% | 0.00% | 0.00% | 23.30% | 17.56% | 7.00% | 15.80% | 0.00% |
YoY Net Profit Growth
| Year | 2012-2013 | 2013-2014 | 2014-2015 | 2015-2016 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -61.65% | -71.11% | -507.69% | 115.72% | -20.39% | 150.75% | -63.08% | -82.35% |
| Change in YoY Net Profit Growth (%) | 0.00% | -9.46% | -436.58% | 623.42% | -136.11% | 171.14% | -213.83% | -19.27% |
Diamines & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2012-2013 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | % |
| 3 Years: | 3% |
| TTM: | -25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | % |
| 3 Years: | -45% |
| TTM: | -75% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | -5% |
| 3 Years: | -8% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 15% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 3:16 pm
Balance Sheet
Last Updated: August 11, 2025, 3:48 pm
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 |
| Reserves | 23.57 | 24.25 | 24.54 | 22.75 | 23.00 | 75.20 | 90.41 | 124.74 | 138.33 | 151.47 |
| Borrowings | 26.34 | 19.53 | 19.75 | 20.10 | 15.56 | 0.30 | 0.00 | 0.00 | 0.00 | 0.03 |
| Other Liabilities | 14.85 | 12.90 | 10.47 | 10.05 | 8.64 | 9.50 | 10.36 | 16.56 | 14.56 | 16.81 |
| Total Liabilities | 74.54 | 66.46 | 64.54 | 62.68 | 56.98 | 94.78 | 110.55 | 151.08 | 162.67 | 178.09 |
| Fixed Assets | 34.51 | 33.23 | 31.51 | 29.30 | 27.33 | 22.47 | 37.55 | 40.06 | 65.38 | 63.79 |
| CWIP | 1.13 | 1.51 | 1.17 | 1.17 | 1.20 | 0.15 | 1.88 | 21.39 | 0.83 | 2.26 |
| Investments | 0.10 | 0.10 | 0.10 | 0.10 | 0.08 | 5.94 | 12.67 | 13.30 | 15.76 | 16.07 |
| Other Assets | 38.80 | 31.62 | 31.76 | 32.11 | 28.37 | 66.22 | 58.45 | 76.33 | 80.70 | 95.97 |
| Total Assets | 74.54 | 66.46 | 64.54 | 62.68 | 56.98 | 94.78 | 110.55 | 151.08 | 162.67 | 178.09 |
Below is a detailed analysis of the balance sheet data for Diamines & Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 9.78 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 9.78 Cr..
- For Reserves, as of Mar 2025, the value is 151.47 Cr.. The value appears strong and on an upward trend. It has increased from 138.33 Cr. (Mar 2024) to 151.47 Cr., marking an increase of 13.14 Cr..
- For Borrowings, as of Mar 2025, the value is 0.03 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2024) to 0.03 Cr., marking an increase of 0.03 Cr..
- For Other Liabilities, as of Mar 2025, the value is 16.81 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.56 Cr. (Mar 2024) to 16.81 Cr., marking an increase of 2.25 Cr..
- For Total Liabilities, as of Mar 2025, the value is 178.09 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 162.67 Cr. (Mar 2024) to 178.09 Cr., marking an increase of 15.42 Cr..
- For Fixed Assets, as of Mar 2025, the value is 63.79 Cr.. The value appears to be declining and may need further review. It has decreased from 65.38 Cr. (Mar 2024) to 63.79 Cr., marking a decrease of 1.59 Cr..
- For CWIP, as of Mar 2025, the value is 2.26 Cr.. The value appears strong and on an upward trend. It has increased from 0.83 Cr. (Mar 2024) to 2.26 Cr., marking an increase of 1.43 Cr..
- For Investments, as of Mar 2025, the value is 16.07 Cr.. The value appears strong and on an upward trend. It has increased from 15.76 Cr. (Mar 2024) to 16.07 Cr., marking an increase of 0.31 Cr..
- For Other Assets, as of Mar 2025, the value is 95.97 Cr.. The value appears strong and on an upward trend. It has increased from 80.70 Cr. (Mar 2024) to 95.97 Cr., marking an increase of 15.27 Cr..
- For Total Assets, as of Mar 2025, the value is 178.09 Cr.. The value appears strong and on an upward trend. It has increased from 162.67 Cr. (Mar 2024) to 178.09 Cr., marking an increase of 15.42 Cr..
Notably, the Reserves (151.47 Cr.) exceed the Borrowings (0.03 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -16.02 | -11.77 | -13.93 | -15.17 | -11.10 | 25.32 | 22.07 | 55.62 | 22.68 | 5.40 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 56.50 | 65.75 | 67.04 | 72.74 | 75.71 | 54.79 | 55.44 | 75.72 | 58.63 | 70.74 |
| Inventory Days | 177.56 | 122.26 | 184.13 | 184.33 | 155.05 | 283.59 | 43.30 | 233.57 | 135.42 | 335.64 |
| Days Payable | 71.12 | 58.50 | 66.67 | 52.30 | 34.46 | 64.90 | 44.80 | 104.92 | 40.49 | 93.05 |
| Cash Conversion Cycle | 162.95 | 129.52 | 184.50 | 204.77 | 196.31 | 273.47 | 53.93 | 204.37 | 153.56 | 313.33 |
| Working Capital Days | -1.31 | -13.93 | 10.88 | 32.12 | 25.54 | 102.61 | 39.61 | 96.39 | 94.37 | 184.52 |
| ROCE % | 9.89% | 6.86% | 5.77% | 5.61% | 23.96% | 48.22% | 15.78% | 3.33% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 2.79 | 16.24 | 42.84 | 17.08 | 21.46 |
| Diluted EPS (Rs.) | 2.79 | 16.23 | 42.80 | 17.08 | 21.46 |
| Cash EPS (Rs.) | 6.59 | 19.15 | 44.66 | 18.79 | 23.29 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 164.82 | 151.38 | 137.51 | 102.41 | 86.87 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 164.82 | 151.38 | 137.51 | 102.41 | 86.87 |
| Revenue From Operations / Share (Rs.) | 73.05 | 106.33 | 113.01 | 67.57 | 64.21 |
| PBDIT / Share (Rs.) | 8.80 | 25.79 | 59.57 | 24.38 | 28.28 |
| PBIT / Share (Rs.) | 5.23 | 22.88 | 57.75 | 22.67 | 26.45 |
| PBT / Share (Rs.) | 4.88 | 22.68 | 57.60 | 22.59 | 26.38 |
| Net Profit / Share (Rs.) | 3.02 | 16.24 | 42.84 | 17.08 | 21.46 |
| NP After MI And SOA / Share (Rs.) | 2.79 | 15.81 | 42.83 | 17.08 | 21.46 |
| PBDIT Margin (%) | 12.04 | 24.25 | 52.71 | 36.07 | 44.04 |
| PBIT Margin (%) | 7.16 | 21.51 | 51.09 | 33.55 | 41.19 |
| PBT Margin (%) | 6.68 | 21.33 | 50.96 | 33.42 | 41.07 |
| Net Profit Margin (%) | 4.13 | 15.27 | 37.90 | 25.28 | 33.42 |
| NP After MI And SOA Margin (%) | 3.82 | 14.87 | 37.90 | 25.28 | 33.42 |
| Return on Networth / Equity (%) | 1.69 | 10.44 | 31.14 | 16.68 | 24.70 |
| Return on Capital Employeed (%) | 3.08 | 14.69 | 40.81 | 21.30 | 29.10 |
| Return On Assets (%) | 1.53 | 9.51 | 27.73 | 15.11 | 22.15 |
| Asset Turnover Ratio (%) | 0.41 | 0.66 | 0.84 | 0.64 | 0.00 |
| Current Ratio (X) | 7.36 | 7.29 | 5.44 | 8.43 | 9.60 |
| Quick Ratio (X) | 4.76 | 5.61 | 4.11 | 8.07 | 7.46 |
| Inventory Turnover Ratio (X) | 1.34 | 2.17 | 3.48 | 2.58 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 18.97 | 14.00 | 29.26 | 17.41 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 16.01 | 13.43 | 26.61 | 16.05 |
| Earning Retention Ratio (%) | 0.00 | 81.03 | 86.00 | 70.74 | 82.59 |
| Cash Earning Retention Ratio (%) | 0.00 | 83.99 | 86.57 | 73.39 | 83.95 |
| Interest Coverage Ratio (X) | 25.34 | 129.35 | 402.75 | 278.96 | 366.92 |
| Interest Coverage Ratio (Post Tax) (X) | 9.69 | 82.43 | 290.61 | 196.48 | 279.45 |
| Enterprise Value (Cr.) | 265.36 | 454.53 | 366.00 | 225.38 | 226.11 |
| EV / Net Operating Revenue (X) | 3.71 | 4.37 | 3.31 | 3.41 | 3.60 |
| EV / EBITDA (X) | 30.81 | 18.01 | 6.28 | 9.45 | 8.17 |
| MarketCap / Net Operating Revenue (X) | 4.29 | 4.73 | 3.55 | 4.02 | 4.11 |
| Retention Ratios (%) | 0.00 | 81.02 | 85.99 | 70.73 | 82.58 |
| Price / BV (X) | 1.90 | 3.32 | 2.92 | 2.65 | 3.04 |
| Price / Net Operating Revenue (X) | 4.29 | 4.73 | 3.55 | 4.02 | 4.11 |
| EarningsYield | 0.01 | 0.03 | 0.10 | 0.06 | 0.08 |
After reviewing the key financial ratios for Diamines & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.79. This value is below the healthy minimum of 5. It has decreased from 16.24 (Mar 24) to 2.79, marking a decrease of 13.45.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.79. This value is below the healthy minimum of 5. It has decreased from 16.23 (Mar 24) to 2.79, marking a decrease of 13.44.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.59. This value is within the healthy range. It has decreased from 19.15 (Mar 24) to 6.59, marking a decrease of 12.56.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 164.82. It has increased from 151.38 (Mar 24) to 164.82, marking an increase of 13.44.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 164.82. It has increased from 151.38 (Mar 24) to 164.82, marking an increase of 13.44.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 73.05. It has decreased from 106.33 (Mar 24) to 73.05, marking a decrease of 33.28.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 8.80. This value is within the healthy range. It has decreased from 25.79 (Mar 24) to 8.80, marking a decrease of 16.99.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.23. This value is within the healthy range. It has decreased from 22.88 (Mar 24) to 5.23, marking a decrease of 17.65.
- For PBT / Share (Rs.), as of Mar 25, the value is 4.88. This value is within the healthy range. It has decreased from 22.68 (Mar 24) to 4.88, marking a decrease of 17.80.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.02. This value is within the healthy range. It has decreased from 16.24 (Mar 24) to 3.02, marking a decrease of 13.22.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.79. This value is within the healthy range. It has decreased from 15.81 (Mar 24) to 2.79, marking a decrease of 13.02.
- For PBDIT Margin (%), as of Mar 25, the value is 12.04. This value is within the healthy range. It has decreased from 24.25 (Mar 24) to 12.04, marking a decrease of 12.21.
- For PBIT Margin (%), as of Mar 25, the value is 7.16. This value is below the healthy minimum of 10. It has decreased from 21.51 (Mar 24) to 7.16, marking a decrease of 14.35.
- For PBT Margin (%), as of Mar 25, the value is 6.68. This value is below the healthy minimum of 10. It has decreased from 21.33 (Mar 24) to 6.68, marking a decrease of 14.65.
- For Net Profit Margin (%), as of Mar 25, the value is 4.13. This value is below the healthy minimum of 5. It has decreased from 15.27 (Mar 24) to 4.13, marking a decrease of 11.14.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.82. This value is below the healthy minimum of 8. It has decreased from 14.87 (Mar 24) to 3.82, marking a decrease of 11.05.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.69. This value is below the healthy minimum of 15. It has decreased from 10.44 (Mar 24) to 1.69, marking a decrease of 8.75.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.08. This value is below the healthy minimum of 10. It has decreased from 14.69 (Mar 24) to 3.08, marking a decrease of 11.61.
- For Return On Assets (%), as of Mar 25, the value is 1.53. This value is below the healthy minimum of 5. It has decreased from 9.51 (Mar 24) to 1.53, marking a decrease of 7.98.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.41. It has decreased from 0.66 (Mar 24) to 0.41, marking a decrease of 0.25.
- For Current Ratio (X), as of Mar 25, the value is 7.36. This value exceeds the healthy maximum of 3. It has increased from 7.29 (Mar 24) to 7.36, marking an increase of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 4.76. This value exceeds the healthy maximum of 2. It has decreased from 5.61 (Mar 24) to 4.76, marking a decrease of 0.85.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.34. This value is below the healthy minimum of 4. It has decreased from 2.17 (Mar 24) to 1.34, marking a decrease of 0.83.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 18.97 (Mar 24) to 0.00, marking a decrease of 18.97.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 16.01 (Mar 24) to 0.00, marking a decrease of 16.01.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 81.03 (Mar 24) to 0.00, marking a decrease of 81.03.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 83.99 (Mar 24) to 0.00, marking a decrease of 83.99.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 25.34. This value is within the healthy range. It has decreased from 129.35 (Mar 24) to 25.34, marking a decrease of 104.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.69. This value is within the healthy range. It has decreased from 82.43 (Mar 24) to 9.69, marking a decrease of 72.74.
- For Enterprise Value (Cr.), as of Mar 25, the value is 265.36. It has decreased from 454.53 (Mar 24) to 265.36, marking a decrease of 189.17.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.71. This value exceeds the healthy maximum of 3. It has decreased from 4.37 (Mar 24) to 3.71, marking a decrease of 0.66.
- For EV / EBITDA (X), as of Mar 25, the value is 30.81. This value exceeds the healthy maximum of 15. It has increased from 18.01 (Mar 24) to 30.81, marking an increase of 12.80.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.29. This value exceeds the healthy maximum of 3. It has decreased from 4.73 (Mar 24) to 4.29, marking a decrease of 0.44.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 81.02 (Mar 24) to 0.00, marking a decrease of 81.02.
- For Price / BV (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has decreased from 3.32 (Mar 24) to 1.90, marking a decrease of 1.42.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.29. This value exceeds the healthy maximum of 3. It has decreased from 4.73 (Mar 24) to 4.29, marking a decrease of 0.44.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Diamines & Chemicals Ltd:
- Net Profit Margin: 4.13%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.08% (Industry Average ROCE: 10.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.69% (Industry Average ROE: 8.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.69
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.76
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 175 (Industry average Stock P/E: 49.74)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.13%
About the Company - Qualitative Analysis
Diamines & Chemicals Ltd. is a Public Limited Listed company incorporated on 12/05/1976 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24110GJ1976PLC002905 and registration number is 002905. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 71.39 Cr. and Equity Capital is Rs. 9.78 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Others | Plot No. 13, PCC Area, Vadodra Gujarat 391350 | info@dacl.co.in http://www.dacl.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Amit Mehta | Executive Chairman |
| Mr. Rajendra Chhabra | Prof.Director |
| Mr. Tanmay Godiawala | Director |
| Mr. Dhruv Mehta | Independent Director |
| Mrs. Kejal Pandya | Independent Director |
| Mr. Priyam Jhaveri | Independent Director |
FAQ
What is the intrinsic value of Diamines & Chemicals Ltd?
Diamines & Chemicals Ltd's intrinsic value (as of 10 October 2025) is 412.58 which is 39.39% higher the current market price of 296.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹291 Cr. market cap, FY2025-2026 high/low of 577/289, reserves of ₹151.47 Cr, and liabilities of 178.09 Cr.
What is the Market Cap of Diamines & Chemicals Ltd?
The Market Cap of Diamines & Chemicals Ltd is 291 Cr..
What is the current Stock Price of Diamines & Chemicals Ltd as on 10 October 2025?
The current stock price of Diamines & Chemicals Ltd as on 10 October 2025 is 296.
What is the High / Low of Diamines & Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Diamines & Chemicals Ltd stocks is 577/289.
What is the Stock P/E of Diamines & Chemicals Ltd?
The Stock P/E of Diamines & Chemicals Ltd is 175.
What is the Book Value of Diamines & Chemicals Ltd?
The Book Value of Diamines & Chemicals Ltd is 165.
What is the Dividend Yield of Diamines & Chemicals Ltd?
The Dividend Yield of Diamines & Chemicals Ltd is 0.34 %.
What is the ROCE of Diamines & Chemicals Ltd?
The ROCE of Diamines & Chemicals Ltd is 3.33 %.
What is the ROE of Diamines & Chemicals Ltd?
The ROE of Diamines & Chemicals Ltd is 1.78 %.
What is the Face Value of Diamines & Chemicals Ltd?
The Face Value of Diamines & Chemicals Ltd is 10.0.